SEC Form 4 · accession 0001225208-17-018119
BOSTON SCIENTIFIC CORP · BSX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric Francis Yves Thepaut
Officer — SVP & Pres, Europe
Period of report
Dec 1, 2017
Accepted (ET)
Dec 4, 2017 · 5:26 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885725
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 1, 2017 | M | 2,327 | $0.00 | A | 113,172 | D | |
| Common Stock | Dec 1, 2017 | F | 512 | $26.15 | D | 112,660 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Deferred Stock UnitsF1,F2 | — | Dec 1, 2017 | M | 2,327 | D | Dec 1, 2019 | Dec 1, 2019 | Common Stock | 2,327 | 4,655 | D |
Explanation of responses
- F1Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
- F2Shares of common stock will be issued to the reporting person in five equal annual installments beginning on December 1, 2015, the first anniversary of the date of grant.